Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Leblond

Showing results (141-150 of 167) with videos related to

Pageof 17
Sort By:
Leukemia|November 26, 2011
Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden ConsortiumW Wiktor-Jedrzejczak, C Dearden, L de Wreede, et al.
British Journal of Haematology|July 23, 1998
Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patientsP Moreau, V Leblond, P Bourquelot, et al.
Leukemia|July 14, 2006
Trisomy 4, a new chromosomal abnormality in Waldenström's macroglobulinemia: a study of 39 casesC Terré, F Nguyen-Khac, C Barin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disordersV Leblond, N Dhedin, M F Mamzer Bruneel, et al.
Seminars in Oncology|April 30, 2003
Transplantation in Waldenstrom's macroglobulinemia--the French experienceO Tournilhac, V Leblond, R Tabrizi, et al.
Blood|March 10, 2001
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trialE Haddad, S Paczesny, V Leblond, et al.
Leukemia|July 24, 2012
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblingsN Kröger, T Zabelina, L de Wreede, et al.
Blood|October 25, 2001
Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory diseaseV Leblond, V Lévy, F Maloisel, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 9, 2005
[French training program for medical students in transfusion medicine. Transfusion Medicine Teachers' College]J-L Wautier, J-J Cabaud, J-P Cazenave, et al.
Seminars in Hematology|April 26, 2023
Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and managementE Terpos, A R Branagan, R García-Sanz, et al.
Pageof 17

Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
Leukemia|November 26, 2011
Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden ConsortiumW Wiktor-Jedrzejczak, C Dearden, L de Wreede, et al.
British Journal of Haematology|July 23, 1998
Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patientsP Moreau, V Leblond, P Bourquelot, et al.
Leukemia|July 14, 2006
Trisomy 4, a new chromosomal abnormality in Waldenström's macroglobulinemia: a study of 39 casesC Terré, F Nguyen-Khac, C Barin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disordersV Leblond, N Dhedin, M F Mamzer Bruneel, et al.
Seminars in Oncology|April 30, 2003
Transplantation in Waldenstrom's macroglobulinemia--the French experienceO Tournilhac, V Leblond, R Tabrizi, et al.
Blood|March 10, 2001
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trialE Haddad, S Paczesny, V Leblond, et al.
Leukemia|July 24, 2012
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblingsN Kröger, T Zabelina, L de Wreede, et al.
Blood|October 25, 2001
Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory diseaseV Leblond, V Lévy, F Maloisel, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 9, 2005
[French training program for medical students in transfusion medicine. Transfusion Medicine Teachers' College]J-L Wautier, J-J Cabaud, J-P Cazenave, et al.
Seminars in Hematology|April 26, 2023
Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and managementE Terpos, A R Branagan, R García-Sanz, et al.
Pageof 17